-
1 Comment
Thyrocare Technologies Limited is currently in a long term uptrend where the price is trading 30.7% above its 200 day moving average.
From a valuation standpoint, the stock is 150.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Thyrocare Technologies Limited's total revenue rose by 30.7% to $1B since the same quarter in the previous year.
Its net income has increased by 17.8% to $324M since the same quarter in the previous year.
Finally, its free cash flow fell by 75.3% to $221M since the same quarter in the previous year.
Based on the above factors, Thyrocare Technologies Limited gets an overall score of 3/5.
Industry | Diagnostics & Research |
---|---|
Sector | Healthcare |
Exchange | NSE |
CurrencyCode | INR |
ISIN | INE594H01019 |
Market Cap | 50B |
---|---|
Target Price | 1007.5 |
Dividend Yield | 2.0% |
Beta | 0.38 |
PE Ratio | 54.89 |
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for THYROCARE.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025